Results for:(80 found)
Sep 19, 2013 10:59AM on Top StocksBy TheStreet Staff

Iclusig is not any more toxic than its competing leukemia drugs and its sales potential remains strong.

Sep 16, 2013 11:57AM on Top StocksBy MSN Money Partner

Under Armour is downgraded to 'neutral,' and Bristol-Myers is upgraded to 'overweight.'

Aug 27, 2013 9:13AM on Top StocksBy Jim Cramer

Sorry to be so prosaic about this, but as long oil's not shooting through the roof, investors need to take very little action.

Aug 14, 2013 4:00PM on Top StocksBy Benzinga

Many factors affect innovations from the pharmaceutical sector.

Jul 31, 2013 10:55AM on Top StocksBy TheStreet Staff

The company must navigate several challenges in order for its leukemia drug Iclusig to become a blockbuster.

Jul 26, 2013 7:07AM on Top StocksBy Benzinga

US markets are set to start the session unchanged as investors digest some key earnings results and await consumer sentiment data.

Jul 25, 2013 6:59AM on Top StocksBy Benzinga

Indication that Europe is improving could not offset the negative sentiment ahead of more earnings and economic data.

VIDEO ON MSN MONEY

DATA PROVIDERS

Copyright © 2014 Microsoft. All rights reserved.

Fundamental company data and historical chart data provided by Morningstar Inc. Real-time index quotes and delayed quotes supplied by Morningstar Inc. Quotes delayed by up to 15 minutes, except where indicated otherwise. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by Morningstar Inc.